+44 (0) 1223 755950
+1 832 327 7413
Orders to United States ship from United States
| Target | Cytomegalovirus pp65 (CMV UL83) |
| Origin | Virus |
| Expression | Recombinant |
| Tested Applications | ELISA, WB |
| Host | E. coli |
| Recommended dilutions | Optimal dilutions/concentrations should be determined by the end user. |
| Conjugation | Unconjugated |
| Form | Liquid |
| Purity | > 95% (10% PAGE, Coomassie staining) |
| Purification | Purified from E. coli by GS-4B Sepharose Affinity Purification. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Shelf Life | At least 12 months. |
| Molecular Weight | 50 kDa |
| Sequence Fragment | Contains the CMV pp65 (UL83) immunodominant regions. |
| Sequence | The exact sequence is proprietary. |
| Tag | GST tag |
| Buffer | 25 mM Tris-HCl, pH 8, 5mM bMe, 8 M Urea. Does not contain preservatives. |
| Specificity | Immunoreactive with CMV positive sera. |
| Concentration | 1 mg/ml |
| Availability | Shipped within 10-20 working days. |
| Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |
| Directions for use | Centrifuge before opening to ensure complete recovery of vial contents. |